Nanobiotix S.A. (EPA:NANO)
France
· Delayed Price · Currency is EUR 2.905
-0.035 (-1.19%)
Apr 24, 2025, 5:35 PM CET
Nanobiotix Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | -11.61 | 30.06 | - | 0.01 | 0.05 | Upgrade
|
| Other Revenue | 4.42 | 6.15 | 4.78 | 2.64 | 2.28 | Upgrade
|
| Revenue | -7.19 | 36.21 | 4.78 | 2.65 | 2.33 | Upgrade
|
| Revenue Growth (YoY) | - | 658.12% | 80.43% | 13.85% | -8.50% | Upgrade
|
| Gross Profit | -7.19 | 36.21 | 4.78 | 2.65 | 2.33 | Upgrade
|
| Selling, General & Admin | 20.53 | 22.05 | 17.86 | 19.43 | 14.61 | Upgrade
|
| Research & Development | 40.54 | 38.4 | 32.64 | 30.38 | 24.33 | Upgrade
|
| Operating Expenses | 61.07 | 60.45 | 50.49 | 49.81 | 38.94 | Upgrade
|
| Operating Income | -68.26 | -24.24 | -45.72 | -47.17 | -36.62 | Upgrade
|
| Interest Expense | -8.09 | -7.98 | -5.84 | -0.67 | -0.33 | Upgrade
|
| Interest & Investment Income | 2.63 | 1.22 | 0.26 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 2.99 | -2.09 | 2.11 | 6.24 | -1.59 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0 | 0 | 0.01 | 4.77 | Upgrade
|
| EBT Excluding Unusual Items | -70.73 | -33.09 | -49.19 | -41.58 | -33.77 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -4.23 | - | - | - | Upgrade
|
| Other Unusual Items | 2.7 | -2.26 | -7.84 | -5.41 | 0.19 | Upgrade
|
| Pretax Income | -68.03 | -39.58 | -57.03 | -47 | -33.58 | Upgrade
|
| Income Tax Expense | 0.1 | 0.12 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Net Income | -68.13 | -39.7 | -57.04 | -47 | -33.59 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 0.06 | - | Upgrade
|
| Net Income to Common | -68.13 | -39.7 | -57.04 | -47.06 | -33.59 | Upgrade
|
| Shares Outstanding (Basic) | 47 | 37 | 35 | 35 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 47 | 37 | 35 | 35 | 24 | Upgrade
|
| Shares Change (YoY) | 27.99% | 5.96% | 0.34% | 42.43% | 12.73% | Upgrade
|
| EPS (Basic) | -1.44 | -1.08 | -1.64 | -1.35 | -1.38 | Upgrade
|
| EPS (Diluted) | -1.44 | -1.08 | -1.64 | -1.35 | -1.38 | Upgrade
|
| Free Cash Flow | -20.4 | -12.8 | -37.2 | -30.1 | -27.63 | Upgrade
|
| Free Cash Flow Per Share | -0.43 | -0.35 | -1.07 | -0.87 | -1.13 | Upgrade
|
| Gross Margin | - | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | - | -66.94% | -957.22% | -1781.83% | -1574.88% | Upgrade
|
| Profit Margin | - | -109.64% | -1194.33% | -1777.97% | -1444.73% | Upgrade
|
| Free Cash Flow Margin | - | -35.36% | -778.79% | -1137.14% | -1188.56% | Upgrade
|
| EBITDA | -67.67 | -23.69 | -44.22 | -45.61 | -34.86 | Upgrade
|
| EBITDA Margin | - | -65.42% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.59 | 0.55 | 1.5 | 1.56 | 1.75 | Upgrade
|
| EBIT | -68.26 | -24.24 | -45.72 | -47.17 | -36.62 | Upgrade
|
| EBIT Margin | - | -66.94% | - | - | - | Upgrade
|
| Revenue as Reported | -7.19 | 36.21 | 4.78 | 2.65 | 2.51 | Upgrade
|
Updated Sep 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.